Metraipolis › archive › dc_4fe1875ee011

Real-world outcomes of faricimab in treatment-naïve patients with neovascular age-related macular degeneration — Europe PMC PMID:42277682

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42277682
DOI
10.1186/s12886-[numero omesso]-w
License (as archived)
solo-consultazione
Archived
2026-10-31T13:56:43.525Z
SHA-256 of the archived text
e01e53eaf875bd0931a6725b3d4aece367df1cdbd9d6295e8bd994e147992fa7
Stable URL of this page
https://metraipolis.com/documento/dc_4fe1875ee011

How to cite

Real-world outcomes of faricimab in treatment-naïve patients with neovascular age-related macular degeneration — Europe PMC PMID:42277682 — Europe PMC (en), https://europepmc.org/article/MED/42277682 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4fe1875ee011 (Metraipolis archive dc_4fe1875ee011, sha256 e01e53eaf875bd0931a6725b3d4aece367df1cdbd9d6295e8bd994e147992fa7)
BibTeX
@misc{dc4fe1875ee011,
  title = {Real-world outcomes of faricimab in treatment-naïve patients with neovascular age-related macular degeneration — Europe PMC PMID:42277682},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42277682},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4fe1875ee011; sha256 e01e53eaf875bd0931a6725b3d4aece367df1cdbd9d6295e8bd994e147992fa7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42277682. Agents can read the archived copy with the MCP tool read_document.